Main Session
Sep
28
SS 21 - Immuno-Radiotherapy and Liquid Biomarkers in Gynecologic Cancer: Toward Precision Care
213 - Circulating Tumor DNA (ctDNA) as an Early Predictive Biomarker of Response In Locally Advanced Cervical Cancer Treated with the Interlace Regimen: A Preliminary Report
Presenter(s)
Bin Gui, MD, MS - Northwell Health, Lake Success, NY